Risk factors for pneumonitis development in patients with platinum-refractory head and neck cancer treated with salvage-line chemotherapy after nivolumab failure

Ari Nishimura, Takane Watanabe, Hiroki Oka, Kengo Nagashima, Hideaki Nishi, Yoshihiko Kumai, Hiroaki Iijima, Kenji Okami, Yasushi Shimizu, Satoshi Kano, Kazue Ito, Tomoko Yamazaki, Hideaki Takahashi, Nobuhiko Oridate, Tomoya Yokota, Taiji Koyama, Naomi Kiyota, Yasuyoshi Sato, Shunji Takahashi, Kyoko Kato, Shigenori Kadowaki, Yoshitaka Honma

Open source

DOI: 10.1007/s10147-026-03231-8
Published: 2026-11-10
Container: International Journal of Clinical Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-03231-8,
  title = {Risk factors for pneumonitis development in patients with platinum-refractory head and neck cancer treated with salvage-line chemotherapy after nivolumab failure},
  author = {Ari Nishimura and Takane Watanabe and Hiroki Oka and Kengo Nagashima and Hideaki Nishi and Yoshihiko Kumai and Hiroaki Iijima and Kenji Okami and Yasushi Shimizu and Satoshi Kano and Kazue Ito and Tomoko Yamazaki and Hideaki Takahashi and Nobuhiko Oridate and Tomoya Yokota and Taiji Koyama and Naomi Kiyota and Yasuyoshi Sato and Shunji Takahashi and Kyoko Kato and Shigenori Kadowaki and Yoshitaka Honma},
  year = {2026},
  journal = {International Journal of Clinical Oncology},
  doi = {10.1007/s10147-026-03231-8},
  url = {https://doi.org/10.1007/s10147-026-03231-8}
}

RIS

TY  - JOUR
TI  - Risk factors for pneumonitis development in patients with platinum-refractory head and neck cancer treated with salvage-line chemotherapy after nivolumab failure
AU  - Ari Nishimura
AU  - Takane Watanabe
AU  - Hiroki Oka
AU  - Kengo Nagashima
AU  - Hideaki Nishi
AU  - Yoshihiko Kumai
AU  - Hiroaki Iijima
AU  - Kenji Okami
AU  - Yasushi Shimizu
AU  - Satoshi Kano
AU  - Kazue Ito
AU  - Tomoko Yamazaki
AU  - Hideaki Takahashi
AU  - Nobuhiko Oridate
AU  - Tomoya Yokota
AU  - Taiji Koyama
AU  - Naomi Kiyota
AU  - Yasuyoshi Sato
AU  - Shunji Takahashi
AU  - Kyoko Kato
AU  - Shigenori Kadowaki
AU  - Yoshitaka Honma
PY  - 2026
JO  - International Journal of Clinical Oncology
DO  - 10.1007/s10147-026-03231-8
UR  - https://doi.org/10.1007/s10147-026-03231-8
ER  -

APA

Nishimura, A., Watanabe, T., Oka, H., Nagashima, K., Nishi, H., Kumai, Y., Iijima, H., Okami, K., Shimizu, Y., Kano, S., Ito, K., Yamazaki, T., Takahashi, H., Oridate, N., Yokota, T., Koyama, T., Kiyota, N., Sato, Y., Takahashi, S., Kato, K., Kadowaki, S., & Honma, Y. (2026). Risk factors for pneumonitis development in patients with platinum-refractory head and neck cancer treated with salvage-line chemotherapy after nivolumab failure. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03231-8

Source records

crossref · retrieved 2026-11-11T01:03:59.156Z